All Stories

  1. Variants of Papillary Thyroid Carcinoma: An Algorithmic Cytomorphology-Based Approach to Cytology Specimens
  2. Announcement: The International System for Reporting Serous Fluid Cytopathology
  3. Ancillary Tests in Breast Cytology: A Practical Guide
  4. The International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology
  5. Role of Cytomorphology in the Era of Liquid Biopsy
  6. Breast Fine Needle Aspiration Biopsy Cytology Using the Newly Proposed IAC Yokohama System for Reporting Breast Cytopathology: The Experience of a Single Institution
  7. Liquid Biopsy: A New Tool in Oncology
  8. Thyroid FNAC: Causes of false-positive results
  9. Invasion in breast lesions: the role of the epithelial-stroma barrier
  10. Stromal Cellular Fragments in Breast Fine Needle Aspirates: Think Outside of the Box
  11. Characterization of HER2 gene amplification heterogeneity in invasive and in situ breast cancer using bright-field in situ hybridization
  12. Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens
  13. Counting invasive breast cancer cells in the HER2 silver in-situ hybridization test: how many cells are enough?
  14. Prognostic value of stromal tumour infiltrating lymphocytes and programmed cell death-ligand 1 expression in breast cancer
  15. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg
  16. Telecytology: “Cells beyond the borders”-The example in two countries
  17. The Role of Liquid Based Cytology and Ancillary Techniques in the Peritoneal Washing Analysis: Our Institutional Experience
  18. P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice
  19. Cytopathology of Follicular Cell Nodules
  20. Expectations and Projections for the Future of Nongynecolgical Cytology 10 Years Ago: Did They Materialize and How Did We Do?
  21. IAC Standardized Reporting of Breast Fine-Needle Aspiration Biopsy Cytology
  22. Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer
  23. The Bethesda System for Reporting Thyroid Cytopathology: proposed modifications and updates for the second edition from an international panel
  24. Utilization of ancillary studies in the cytologic diagnosis of respiratory lesions: The papanicolaou society of cytopathology consensus recommendations for respiratory cytology
  25. The expression of monocarboxylate transporters in thyroid carcinoma can be associated with the morphological features of BRAF V600E mutation
  26. Morphological features that can predictBRAFV600E-mutated carcinoma in paediatric thyroid cytology
  27. Prognostic significance of monocarboxylate transporter expression in oral cavity tumors
  28. MicroRNA signatures in cytopathology: Are they ready for prime time?
  29. Application of the 2013 ASCO/CAP guideline and the SISH technique for HER2 testing of breast cancer selects more patients for anti-HER2 treatment
  30. Cytological Criteria for Predicting the Luminal Phenotype of Breast Carcinoma
  31. The Bethesda System for Reporting Thyroid Cytopathology: Proposed Modifications and Updates for the Second Edition from an International Panel
  32. When Morphology Meets Somatic Mutations: The New Possible Scenario in Thyroid Fine-Needle Aspiration
  33. Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical management
  34. Phyllodes tumours of the breast: a consensus review
  35. Molecular diagnosis of infectious diseases using cytological specimens
  36. Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials): Table 2.
  37. The diagnostic and prognostic role of liquid-based cytology: are we ready to monitor therapy and resistance?
  38. Somatic mutations in solid tumors: a spectrum at the service of diagnostic armamentarium or an indecipherable puzzle? The morphological eyes looking for BRAF and somatic molecular detections on cyto-histological samples
  39. Targeting lactate transport suppresses in vivo breast tumour growth
  40. Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer
  41. EGF induces microRNAs that target suppressors of cell migration: miR-15b targetsMTSS1in breast cancer
  42. Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
  43. Navigator‐3, a modulator of cell migration, may act as a suppressor of breast cancer progression
  44. The difficulty of lobular breast carcinoma's diagnosis in cytology
  45. Editorial
  46. Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer
  47. Thyroid FNA: International perspectives from the European Congress of Cytopathology-Can we cross the bridge of classifications?
  48. The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: An institutional experience
  49. Histopathological and in vivo evidence of regucalcin as a protective molecule in mammary gland carcinogenesis
  50. Pitfalls in the cytological assessment of thyroid nodules
  51. Utilization of Molecular Testing in Thyroid Cytology
  52. Is thyroid gland only a “land” for primary malignancies? role of morphology and immunocytochemistry
  53. Fine-needle aspiration cytology samples: a good source of material for evaluating biomarkers in breast cancer
  54. Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment
  55. The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype
  56. Topoisomerase II-alfa gene as a predictive marker of response to anthracyclines in breast cancer
  57. Training and practice of cytotechnologists: a discussion forum focused on Europe
  58. Primary relapse site pattern in women with triple-negative breast cancer
  59. Morphological parameters able to predictBRAFV600E-mutated malignancies on thyroid fine-needle aspiration cytology: Our institutional experience
  60. p-mTOR expression is associated with better prognosis in luminal breast carcinoma
  61. Is morphology alone able to predict BRAF-mutated malignancies on thyroid FNAC?
  62. Fibromatosis-like metaplastic carcinoma of the breast has a claudin-low immunohistochemical phenotype
  63. Metastatic breast cancer: mechanisms and opportunities for cytology
  64. Putting an eye on cytological specimens: An audit of the clinical impact of thyroid fine-needle aspiration in different health care settings
  65. Ancillary Studies, Including Immunohistochemistry and Molecular Studies, in Lung Cytology
  66. Growing indication for FNA to study and analyze tumor heterogeneity at metastatic sites
  67. Application of cytological samples for molecular biology
  68. A Journey Through Breast Cancer Research
  69. Analysis of Nondiagnostic Results in a Large Series of Thyroid Fine-Needle Aspiration Cytology Performed over 9 Years in a Single Center
  70. Characterization of monocarboxylate transporters (MCTs) expression in soft tissue sarcomas: distinct prognostic impact of MCT1 sub-cellular localization
  71. Detection of Common and Less FrequentEGFRMutations in Cytological Samples of Lung Cancer
  72. Expression of PTEN in Endometrial Liquid-Based Cytology
  73. Liquid-Based Cytology in Fine-Needle Aspiration of Breast Lesions: A Review
  74. The Nightmare of Indeterminate Follicular Proliferations: When Liquid-Based Cytology and Ancillary Techniques are not a Moon Landing but a Realistic Plan
  75. Differential sensitivities to lactate transport inhibitors of breast cancer cell lines
  76. Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: Key events in the progression from an in situ to an invasive breast carcinoma
  77. Lobular Neoplasia of the Breast Revisited With Emphasis on the Role of E-Cadherin Immunohistochemistry
  78. Clinicopathological significance of ERCC1 expression in breast cancer
  79. The hemopexin domain of MMP3 is responsible for mammary epithelial invasion and morphogenesis through extracellular interaction with HSP90 
  80. Effects of a human compact anti-ErbB2 antibody on gastric cancer
  81. Thyroid fine-needle aspiration cytology: Is there a place to virtual cytology?
  82. Nonoptical Massive Parallel DNA Sequencing ofBRCA1andBRCA2Genes in a Diagnostic Setting
  83. CCAAT/Enhancer Binding Protein β (C/EBPβ) Isoforms as Transcriptional Regulators of the Pro-Invasive CDH3/P-Cadherin Gene in Human Breast Cancer Cells
  84. P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model
  85. Marluce Bibbo Retires as Editor-in-Chief of Acta Cytologica
  86. p40: A p63 Isoform Useful for Lung Cancer Diagnosis – A Review of the Physiological and Pathological Role of p63
  87. Pre-analytic steps for molecular testing on thyroid fine-needle aspirations: The goal of good results
  88. Future Directions
  89. Fibroadenoma
  90. Mucinous Lesions
  91. Epithelial E- and P-cadherins: Role and clinical significance in cancer
  92. Molecular biology and cytopathology. Principles and applications
  93. Cytopathologie moléculaire. Outils et applications
  94. Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types
  95. Multinational study of oestrogen and progesterone receptor immunocytochemistry on breast carcinoma fine needle aspirates
  96. Cytology for pathologists: two sides of the same coin or different views of the same side?
  97. Molecular diagnostics and the training of future tissue- and cell-based pathologists
  98. Reappraisal of immunohistochemical profiling of special histological types of breast carcinomas: a study of 121 cases of eight different subtypes
  99. Characterization of PAR1 and FGFR1 expression in invasive breast carcinomas: Prognostic significance
  100. Molecular alterations in endometrial archived liquid-based cytology
  101. High-Throughput Molecular Analysis from Leftover of Fine Needle Aspiration Cytology of Mammographically Detected Breast Cancer
  102. Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas
  103. CD147 immunohistochemistry discriminates between reactive mesothelial cells and malignant mesothelioma
  104. Cancer stem cell markers in breast neoplasias: their relevance and distribution in distinct molecular subtypes
  105. P‐Cadherin Is Coexpressed with CD44 and CD49f and Mediates Stem Cell Properties in Basal‐like Breast Cancer
  106. Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis
  107. Lactate-Induced IL-8 Pathway in Endothelial Cells--Letter
  108. Benign and malignant apocrine lesions of the breast
  109. Role of monocarboxylate transporters in human cancers: state of the art
  110. Cadherin Cell Adhesion System in Canine Mammary Cancer: A Review
  111. Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression
  112. Role of ancillary studies in fine-needle aspiration from selected tumors
  113. Canine mammary tumours: A quantitative DNA study using static cytometry
  114. Molecular phenotypes of matched in situ and invasive components of breast carcinomas
  115. Immunocytochemistry in Europe: results of the European Federation of Cytology Societies (EFCS) inquiry
  116. Nottingham Prognostic Index in Triple-Negative Breast Cancer: a reliable prognostic tool?
  117. Possible use and role of molecular techniques in fine-needle aspiration cytology (FNAC) practice
  118. Wound healing activity of the human antimicrobial peptide LL37
  119. Authors’ response
  120. (Cyto)pathology and sequencing: Next (or last) generation?
  121. The danger to cytopathology of over-specialization and its relevance for histopathology
  122. Expression of CK19 in invasive breast carcinomas of special histological types: implications for the use of one-step nucleic acid amplification
  123. A letter yet to receive a reply
  124. P-cadherin role in normal breast development and cancer
  125. The Bethesda Terminology for Reporting Thyroid Cytopathology: From Theory to Practice in Europe
  126. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
  127. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions Vitamin D pathways unbalanced in breast lesions
  128. Cervical cancer screening in Mediterranean countries: implications for the future
  129. Potential role of PI3K inhibitors in the treatment of breast cancer
  130. Breast cancer prognostic classification in the molecular era: the role of histological grade
  131. Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma
  132. ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBP  in CDH3 gene activation
  133. Diagnostic terminology for reporting thyroid fine needle aspiration cytology: European Federation of Cytology Societies thyroid working party symposium, Lisbon 2009
  134. Expression and prognostic significance of CK19 in canine malignant mammary tumours
  135. PIKing the right isoform: the emergent role of the p110β subunit in breast cancer
  136. Angiogenesis and Breast Cancer
  137. Cytology Education in the 21st Century: Living in the Past or Crossing the Rubicon?
  138. Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44
  139. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues
  140. The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours
  141. Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells
  142. Cytological criteria to predict basal phenotype of breast carcinomas
  143. Vessel density assessed by endoglin expression in breast carcinomas with different expression profiles
  144. Evaluation of HER2 in breast cancer: reality and expectations
  145. The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer
  146. Regucalcin is under-expressed in human breast and prostate cancers: Effect of sex steroid hormones
  147. HER2+ breast cancer: How to evaluate?
  148. Mixed micropapillary–ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components
  149. Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
  150. Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours
  151. Monoubiquitinylation Regulates Endosomal Localization of Lst2, a Negative Regulator of EGF Receptor Signaling
  152. Fine-Needle Aspiration, an Efficient Sampling Technique for Bacteriological Diagnosis of Nonulcerative Buruli Ulcer
  153. Survey of medical training in cytopathology carried out by the journal Cytopathology
  154. Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients
  155. A comparative study of recombinant and native frutalin binding to human prostate tissues
  156. Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down
  157. Fine-needle aspiration as an alternative method for frozen tissue banking of breast cancer
  158. Possible Relationship between Basal-Like Breast Carcinoma and Age
  159. Lactoferrin and Cancer Disease Prevention
  160. Assessment of cell proliferation and prognostic factors in canine mammary gland tumors
  161. KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loops
  162. STEAP1 is over-expressed in breast cancer and down-regulated by 17β-estradiol in MCF-7 cells and in the rat mammary gland
  163. Increasing Expression of Monocarboxylate Transporters 1 and 4 Along Progression to Invasive Cervical Carcinoma
  164. The role of breast FNAC in diagnosis and clinical management: a survey of current practice
  165. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis?
  166. Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification
  167. EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy
  168. Expression of E-cadherin, P-cadherin and β-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival
  169. Letter to the Editor
  170. Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas
  171. Lymphangiogenesis: from the pig embryos to cancer
  172. Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival
  173. Characterization of oligoadenylate synthetase-1 expression in rat mammary gland and prostate: effects of 17β-estradiol on the regulation of OAS1g in both tissues
  174. Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast
  175. Evaluation of parathyroid gland angiogenesis in chronic kidney disease associated with secondary hyperparathyroidism
  176. Induction of COX-2 expression by acrolein in the rat model of hemorrhagic cystitis
  177. Importance of TP53 codon 72 and intron 3 duplication 16bppolymorphisms in prediction of susceptibility on breast cancer
  178. Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas
  179. Carcinoma de mama: novos conceitos na classificação
  180. The investigation of DNA repair polymorphisms with histopathological characteristics and hormone receptors in a group of Brazilian women with breast cancer
  181. Regucalcin is expressed in rat mammary gland and prostate and down-regulated by 17β-estradiol
  182. Peritumoural, but not intratumoural, lymphatic vessel density and invasion correlate with colorectal carcinoma poor-outcome markers
  183. Angiogenesis, haemostasis and cancer: new paradigms and old concerns
  184. How useful is the assessment of lymphatic vascular density in oral carcinoma prognosis?
  185. The expression of Wilms’ tumour-1 and Ca125 in invasive micropapillary carcinoma of the breast
  186. A quality assurance exercise to evaluate the accuracy and reproducibility of chromogenic in situ hybridisation for HER2 analysis in breast cancer
  187. Cells carry the clue for targeted treatment: a new horizon for cytopathology
  188. Lymphatic vessel density and epithelial D2-40 immunoreactivity in pre-invasive and invasive lesions of the uterine cervix
  189. P-cadherin expression in breast cancer: a review
  190. The future of cytopathology in Europe. Will the wider use of HPV testing have an impact on the provision of cervical screening?
  191. Molecular techniques in cytopathology practice
  192. A reciprocal tensin-3–cten switch mediates EGF-driven mammary cell migration
  193. Cyclooxygenase-2 expression on ifosfamide-induced hemorrhagic cystitis in rats
  194. XRCC1 Arg399Gln and RAD51 5′UTR G135C polymorphisms and their outcome in tumor aggressiveness and survival of Portuguese breast cancer patients
  195. Cyclooxygenase-2 and Epidermal Growth Factor Receptor Expressions in Different Histological Subtypes of Cervical Carcinomas
  196. The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer
  197. Evaluation of accuracy of fine needle aspiration cytology for diagnosis of canine mammary tumours: comparative features with human tumours
  198. Caveolin 1 Is Overexpressed and Amplified in a Subset of Basal-like and Metaplastic Breast Carcinomas: A Morphologic, Ultrastructural, Immunohistochemical, and In situ Hybridization Analysis
  199. Gynecological cytology: Too old to be a pop star but too young to die
  200. Immunohistochemical expression and distribution of VEGFR-3 in malignant mesothelioma
  201. Molecular Analysis of c-KitandPDGFRAin GISTs Diagnosed by EUS
  202. P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ
  203. FGFR1 Emerges as a Potential Therapeutic Target for Lobular Breast Carcinomas
  204. HER2 evaluation using the novel rabbit monoclonal antibody SP3 and CISH in tissue microarrays of invasive breast carcinomas
  205. DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population
  206. BRCA1 dysfunction in sporadic basal-like breast cancer
  207. Fine needle aspiration cytology: a survey of current European practice
  208. Thyroid cytology: FNA is still the best diagnostic approach
  209. Metaplastic breast carcinomas are basal-like tumours
  210. Investigation of human papillomavirus by hybrid capture II in cervical carcinomas including 113 adenocarcinomas and related lesions
  211. Selecting Antibodies to Detect HER2 Overexpression by Immunohistochemistry in Invasive Mammary Carcinomas
  212. Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization
  213. Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue
  214. EGFR amplification and lack of activating mutations in metaplastic breast carcinomas
  215. Insuficiencia cardíaca y hospitalización: ¿son los mismos pacientes?
  216. Infection with Mycobacterium ulcerans Induces Persistent Inflammatory Responses in Mice
  217. P-Cadherin Overexpression Is an Indicator of Clinical Outcome in Invasive Breast Carcinomas and Is Associated with CDH3 Promoter Hypomethylation
  218. Overexpression of platelet-derived growth factor receptor α in breast cancer is associated with tumour progression
  219. p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas
  220. P-cadherin expression in glandular lesions of the uterine cervix detected by liquid-based cytology
  221. VEGFR-3 expression in breast cancer tissue is not restricted to lymphatic vessels
  222. Fluorescence in situ hybridization, comparative genomic hybridization, and other molecular biology techniques in the analysis of effusions
  223. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity
  224. Typical medullary breast carcinomas have a basal/myoepithelial phenotype
  225. P-Cadherin Is Up-Regulated by the Antiestrogen ICI 182,780 and Promotes Invasion of Human Breast Cancer Cells
  226. c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors
  227. c-KIT and PDGFRA in breast phyllodes tumours: overexpression without mutations?
  228. Evidence for the Notch Signaling Pathway on the Role of Estrogen in Angiogenesis
  229. Angiogenesis: now and then
  230. Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers
  231. Bilateral Gonadoblastomas in a Dog with Mixed Gonadal Dysgenesis
  232. Glutathione S-Transferase Genotype GSTM1 as a Predictor of Elevated Angiogenic Phenotype in Patients with Early Onset Breast Cancer
  233. P-Cadherin Expression in Canine Mammary Tissues
  234. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2
  235. Chronobiology and Breast Cancer
  236. Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray
  237. c-myc, not her-2/neu, can predict the prognosis of breast cancer patients: how novel, how accurate, and how significant?
  238. p63: A Novel Myoepithelial Cell Marker in Canine Mammary Tissues
  239. Immunohistochemical study of the expression of E-cadherin in canine mammary tumours
  240. Protocol for the anatomopathological examination of canine mammary tumors
  241. Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast
  242. Lymphangiogenesis in tumors: What do we know?
  243. 17 -Estradiol-Mediated Vessel Assembly and Stabilization in Tumor Angiogenesis Requires TGF  and EGFR Crosstalk
  244. Role of the Estrogen Antagonist ICI 182,780 in Vessel Assembly and Apoptosis of Endothelial Cells
  245. p63 expression in sarcomatoid/metaplastic carcinomas of the breast
  246. p63-driven Nuclear Accumulation of β-Catenin is Not a Frequent Event in Human Neoplasms
  247. Maspin expression in normal skin and usual cutaneous carcinomas
  248. Oncogenes, granules and breast cancer: what has c-myc to do with apocrine changes?
  249. Pleomorphic lobular carcinoma of the canine mammary gland: histopathologic and immunohistochemical features
  250. p63 staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast
  251. Criteria for Definition of Hereditary Breast Cancer in a Clinic Perspective
  252. p63 expression in normal skin and usual cutaneous carcinomas
  253. Evaluation of breast cancer metastases in pleural effusions by molecular biology techniques
  254. Naked nuclei revisited: p63 Immunoexpression
  255. Invasive micropapillary carcinoma of the dog mammary gland: a case report
  256. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer
  257. Inflammatory pseudotumour of the spleen in a dog
  258. Fine-needle aspiration cytology of pulmonary rheumatoid nodule: Case report and review of the major cytologic features
  259. Epithelioid malignant peripheral nerve sheath tumour: case report and review of the previously published cases
  260. Primary epithelial malignant mesothelioma of the pericardium with deciduoid features: Cytohistologic and immunohistochemical study
  261. Aberrant P-Cadherin Expression: Is it Associated with Estrogen-Independent Growth in Breast Cancer?
  262. Análisis de mutaciones en los genes BRCA1 y BRCA2 en pacientes con cáncer de mama y ovario del norte de Portugal y Galicia
  263. Angiogenesis in lymph node metastases
  264. Erratum
  265. Intradermal spindle cell/pleomorphic lipoma of the vulva: case report and review of the literature
  266. Maspin is expressed in the nuclei of breast myoepithelial cells
  267. P-cadherin expression in canine lactating mammary gland
  268. P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast
  269. Pediatric Pigmented Dermatofibrosarcoma Protuberans (Bednář Tumor): Case Report and Review of the Literature with Emphasis on the Differential Diagnosis
  270. Vascular Endothelial Growth Factor, Transforming Growth Factor-α, and Estrogen Receptors: Possible Cross-Talks and Interactions
  271. CD99/MIC-2 surface protein expression in breast carcinomas
  272. Use of cell block preparation for morphological, immunocytochemistry, and ploidy analysis in ThinPrep® monolayer preparations
  273. A new methodology for the improvement of diagnostic immunohistochemistry in canine veterinary pathology: automated system using human monoclonal and polyclonal antibodies
  274. Immunohistochemical study of the expression of MUC5AC and MUC6 in breast carcinomas and adjacent breast tissues
  275. Maspin Expression in Myoepithelial Tumors of the Breast
  276. Cytological findings in cystic hypersecretory ductal carcinoma of the breast: a potential pitfall in mammary cytology
  277. Invasive medullary thymoma associated with myasthenia gravis: an unusual case
  278. Expression of TGF-alpha and EGFR in Breast Cancer and its Relation to Angiogenesis
  279. Immunohistochemical study of hormonal receptors and cell proliferation in normal canine mammary glands and spontaneous mammary tumours
  280. Primary acinic cell-like carcinoma of the breast-a variant with good prognosis?
  281. First Intercontinental Congress of Pathology
  282. Evaluation of Numerical Abnormalities of Chromosomes 1 and 17 in Proliferative Epithelial Breast Lesions Using Fluorescence in situ Hybridization
  283. Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas?
  284. MUC 5 expression in breast carcinomas
  285. Cytological diagnosis of a metastatic canine mammary tumor in pleural effusion
  286. DNA Measurement and Immunohistochemical characterization of Epithelial and Mesenchymal Cells in Canine Mixed Mammary Tumours: Putative Evidence for a Common Histogenesis
  287. Assessment of cell proliferation by Ki‐67 staining and flow cytometry in fine needle aspirates (FNAs) of reactive lymphadenitis and non‐Hodgkin's lymphomas
  288. TGF-α and Angiogenesis
  289. Fine Needle Aspiration as a Tool To Establish Primary Human Breast Cancer Cultures in Vitro
  290. Predictive Markers for Node Metastases in Breast Cancer
  291. Bilateral apocrine carcinoma of the breast Molecular and immunocytochemical evidence for two independent primary tumours
  292. Pseudoangiomatous hyperplasia of mammary stroma associated with gynaecomastia
  293. Histological and immunological reaction of cattle skin to first-instar larvae of Dermatobia hominis
  294. Estimation of Growth Fraction in Fine Needle Aspirates from Non-Hodgkin’s Lymphoma Using Anti–Proliferating Cell Nuclear Antigen
  295. Expression of Sialyl-Tn in Breast Cancer Correlation with Prognostic Parameters
  296. Proliferating cell nuclear antigen (PCNA) in non-hodgkin’s lymphomas: correlation with working formulation and kiel classification in formalin-fixed paraffin-embedded material
  297. Simple mucin-type carbohydrate antigens (T, sialosyl-T, Tn and sialosyl-Tn) in breast carcinogenesis
  298. Estimation of estrogen receptor content in fine-needle aspirates from breast cancer using the monoclonal antibody 1d5 and microwave oven processing: Correlation with paraffin embedded and frozen sections determinations
  299. Multistep progression from an oestrogen-dependent growth towards an autonomous growth in breast carcinogenesis
  300. p53 protein expression and nuclear DNA content in breast intraductal proliferations
  301. Pancreatic mucinous cystadenocarcinoma with a mural nodule of anaplastic carcinoma
  302. Immunohistochemical Characterisation of Probable Intravascular Haematopoiesis in the Vasa Rectae of the Renal Medulla in Acute Tubular Necrosis
  303. CEA content in breast lesions
  304. The Proliferating Cell Nuclear Antigen Index in Breast Aarcinomas does not Correlate with Mitotic Index and Estrogen Receptor Immunoreactivity
  305. Acinic cell carcinoma arising in nasal cavity: Diagnosis by fine-needle aspiration
  306. Altered foci of hepatocytes in rats initiated with diethylnitrosamine after prolonged fasting
  307. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): Cytomorphologic analysis on fine-needle aspirates
  308. Renal interstitial foam cells are macrophages
  309. Rhabdomyosarcoma in a Congenital Pigmented Nevus
  310. Carcinoid tumour of male breast diagnosed by fine needle aspiration
  311. Neuroendocrine (merkel-cell) carcinoma of the skin: Immunocytochemical and cytomorphologic analysis on fine-needle aspirates
  312. S-100 protein: Is it useful as a tumour marker in diagnostic immunocytochemistry?
  313. Adenoid cystic carcinoma of trachea metastatic to the placenta